BPC-157 vs Wolverine (BPC-157 + TB-500): What Is the Difference?
Wolverine is not more BPC-157 — it is half the BPC-157 of a standalone vial, with a second repair peptide added.
Overview
BPC-157 is a single repair peptide, originally found in stomach fluid, studied around how new blood vessels form and how repair signals move through tissue.
Wolverine is one 10 mg vial holding BPC-157 (5 mg) together with TB-500 (5 mg), a second repair peptide studied around cell movement and wound healing.
The difference, without the jargon
The key thing to see is that Wolverine contains 5 mg of BPC-157, half of a standalone 10 mg vial — so the choice is about whether you want one mechanism at full amount or two mechanisms in one vial. On its own, BPC-157 is one of the easiest compounds to work with and any result is simple to attribute to it. Add TB-500 and you gain a complementary, non-overlapping repair mechanism, but you also inherit TB-500's fussier side: it reacts with light and air, so the whole blend has to be kept dark and portioned early. One variable and easy handling, or two mechanisms with a little more care.
Common questions
Is Wolverine just a bigger dose of BPC-157?
No. It holds 5 mg of BPC-157 plus 5 mg of TB-500 in one 10 mg vial. The added value is a second repair mechanism, not more of the first.
Which is easier to handle?
BPC-157 alone. It shrugs off light and dissolves in plain water. The blend follows TB-500's rules instead — keep it dark and portion it early — because TB-500 is the light-sensitive half.
Why combine BPC-157 and TB-500 at all?
Their mechanisms do not overlap — angiogenesis and growth-factor signalling for one, cell migration for the other — so they are studied together to cover two repair routes in a single preparation.
Technical reference below
How they actually differ
Wolverine is a 10 mg vial holding 5 mg of BPC-157 — half a standalone vial — plus 5 mg of TB-500. So it is not more BPC-157 — it is BPC-157 with a second, complementary repair mechanism added: TB-500's cell-migration pathway alongside BPC-157's angiogenesis and growth-factor signalling. The trade is clarity for breadth. BPC-157 alone is one of the most forgiving compounds here and any result is easy to attribute; the blend inherits TB-500's light sensitivity, so the whole vial must be kept dark and portioned early.
BPC-157 — origin
BPC-157 is a 15-amino-acid sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) isolated from a larger protein found in human gastric juice. Its provenance is the reason for one of its most-cited laboratory properties: it was characterised as remaining intact in gastric-fluid conditions that rapidly hydrolyse most peptides.
Wolverine (BPC-157 + TB-500) — origin
Wolverine combines the two most-studied tissue-repair peptides in a single 10 mg vial: BPC-157 (5 mg) and TB-500 (5 mg). It inherits the handling profile of both — the forgiving, gastric-derived BPC-157 and the oxidation-sensitive Thymosin-Beta-4 fragment TB-500 — so the blend is handled to the stricter of the two.
BPC-157 research themes
Preclinical work has examined interactions with VEGFR2 signalling and vessel formation in tissue models.
The compound's gastric-juice provenance drove an early and substantial literature in GI mucosal research models.
Studies have investigated fibroblast behaviour and collagen organisation in tendon and ligament models.
A recurring theme in published work is modulation of the NO system in animal models.
Wolverine (BPC-157 + TB-500) research themes
BPC-157 is studied around angiogenesis and growth-factor signalling; TB-500 around actin-mediated cell migration — non-overlapping routes into tissue repair.
Studied together in connective-tissue and wound-healing research designs where both mechanisms are of interest.
Because their mechanisms do not overlap, the two are frequently examined in parallel rather than as substitutes for one another.
BPC-157 handling
- Let the sealed vial reach room temperature before breaking the seal — opening a cold vial draws in moist air and the lyophilized cake is hygroscopic.
- Do not vortex. Swirl until the cake clears; the peptide dissolves in seconds without agitation.
- Label aliquots with reconstitution date and diluent, since the working window depends on which solvent was used.
Wolverine (BPC-157 + TB-500) handling
- Reach room temperature before opening; the cake is hygroscopic.
- Add diluent gently down the wall and swirl; do not shake or vortex.
- Keep out of light and portion early, since every opening exposes the oxidation-sensitive TB-500 component to fresh air.
Both third-party tested
BPC-157 and Wolverine (BPC-157 + TB-500) are third-party tested for HPLC purity and content, with the Certificate of Analysis for your batch available on request. Enter a lot number to pull a published COA.
BPC-157 reference
Related comparisons
BPC-157 and Wolverine (BPC-157 + TB-500) are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.